FDA.reportPublic FDA data

Application 090753

Type
ANDA
Sponsor
PAR PHARM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SUMATRIPTAN; NAPROXEN SODIUMSUMATRIPTAN; NAPROXEN SODIUMTABLET; ORAL85MG; 500MGNoNo

Source provenance: Browse the complete Orange Book source catalog.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.